To embed, copy and paste the code into your website or blog:
While the COVID-19 pandemic made 2020 a trying year, one unintended benefit was that the Florida legislature allowed pharmacists to further expand their scope of practice to help patients with certain chronic conditions through collaborative practice agreements. Though, as discussed below, they did not make it easy.
The Board of Pharmacy (the “Board”) “collaborated” with the Board of Medicine and the Board of Osteopathic Medicine to develop rules addressing both collaborative practice and the test and treat protocols. The rules set forth in Chapter 64B16-31, Florida Administrative Code, became final on October 20, 2020. We previously addressed the scope of these arrangements a blog post,